Serodiagnosis of Human Strongyloidiasis in Brazil and Peru Using Strongyloides venezuelensis Antigens: A Comparative Study in Endemic Settings
Parasite Immunology · 2026
DOI: 10.1111/pim.70109 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Parasite Immunology, 2026. Verfasst von William Henry Roldán und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Investigação Médica - LIM/06 (Imunopatologia da Esquistossomose) do Hospital das Clínicas da Faculdade de Medicina da Universidade de …. Hauptthemen laut MEDLINE: Strongyloidiasis, Antigens, Helminth, Strongyloides, Antibodies, Helminth. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Strongyloidiasis is a neglected tropical disease caused by the soil‐transmitted helminth Strongyloides stercoralis . Immunological assays employing heterologous antigens from Strongyloides venezuelensis represent a valuable alternative to parasitological diagnosis. In this study, we evaluated the diagnostic performance of different antigenic preparations derived from S. venezuelensis infective larvae (L3) for the detection of anti‐ Strongyloides IgG antibodies in sera from Brazilian and Peruvian individuals. Total soluble (S‐L3), membrane (M‐L3), cuticular (C‐L3) and excretory/secretory (ES‐L3) antigenic extracts were assessed using enzyme‐linked immunosorbent assay (ELISA). Overall, Brazilian sera showed higher reactivity than Peruvian sera to all antigenic preparations. Both S‐iL3 and ES‐L3 demonstrated excellent diagnostic performance with samples from both countries, showing 100% sensitivity and specificities of 97.4% and 100%, respectively. When a single cut‐off value applicable to both populations was adopted, S‐L3 showed the best overall performance, achieving 100% sensitivity and 98.7% specificity at a cut‐off of 0.367, or 97.5% sensitivity and 100% specificity at a cut‐off of 0.416, followed by ES‐L3, C‐L3 and M‐L3. Heterologous antigenic extracts from S. venezuelensis , particularly S‐L3, may represent a useful alternative for the serological diagnosis of S. stercoralis infection in endemic settings such as Brazil and Peru.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Investigação Médica - LIM/06 (Imunopatologia da Esquistossomose) do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
- Laboratorio de Parasitología, Instituto de Medicina Tropical "Alexander Von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Perú.
ORCID-Profile: William Henry Roldán, Marco Canales, Maria Angelica Terashima, Silvia Vanessa Lourenço, Ronaldo Cesar Borges Gryschek, Fabiana Martins de Paula
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Roldán, W. H., Corral, M. A., Meisel, D. M. C. L., Canales, M., Terashima, M. A., Lourenço, S. V., Gryschek, R. C. B., & de Paula, F. M. (2026). Serodiagnosis of Human Strongyloidiasis in Brazil and Peru Using Strongyloides venezuelensis Antigens: A Comparative Study in Endemic Settings. Parasite Immunology. https://doi.org/10.1111/pim.70109
Vancouver
Roldán WH, Corral MA, Meisel DMCL, Canales M, Terashima MA, Lourenço SV, et al. Serodiagnosis of Human Strongyloidiasis in Brazil and Peru Using Strongyloides venezuelensis Antigens: A Comparative Study in Endemic Settings. Parasite Immunology. 2026. doi:10.1111/pim.70109
BibTeX
@article{Roldn2026,
author = {Roldán, William Henry and Corral, Marcelo Andreetta and Meisel, Dirce Mary Correia Lima and Canales, Marco and Terashima, Maria Angelica and Lourenço, Silvia Vanessa and Gryschek, Ronaldo Cesar Borges and de Paula, Fabiana Martins},
title = {Serodiagnosis of Human Strongyloidiasis in Brazil and Peru Using Strongyloides venezuelensis Antigens: A Comparative Study in Endemic Settings},
journal = {Parasite Immunology},
year = {2026},
doi = {10.1111/pim.70109}
}
EUVIMED